Jeffrey A. Jackson - Concepedia

Author

Jeffrey A. Jackson

Also Known As

J A Jackson, J. A. JACKSON, J. A. Jackson, JEFFREY A. JACKSON, Jackson, Jeffrey A., Jeffrey A Jackson, Jeffrey A. Jackson, Jeffrey Jackson

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Diabetes & Endocrine Associates Scott & White Memorial Hospital University of Nottingham University of Southern California

About

Jeffrey A. Jackson is an author at Eli Lilly (United States) specializing in medicine, diabetes, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	601
2	Diabetes	4	4	131
3	Public Health	2	2	68
4	Endocrinology	2	2	242
5	Health Sciences	1	1	15

Jeffrey A. Jackson

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Bone Histomorphometry in Hypogonadal and Eugonadal Men with Spinal Osteoporosis* Jeffrey A. Jackson, Michael Kleerekoper, Michael A. Parfitt, The Journal of Clinical Endocrinology & Metabolism Bone DiseaseUrologyBone HealthSymptomatic Spinal OsteoporosisIdiopathic Osteoporosis	1987	202
Testosterone Deficiency As a Risk Factor for Hip Fractures in Men: A Case-Control Study Jeffrey A. Jackson, Mark W. Riggs, A. Michael Spiekerman The American Journal of the Medical Sciences Bone DiseaseUrologyAndrologyBone HealthRisk Factor	1992	188
Progressive supranuclear palsy: Clinical features and response to treatment in 16 patients Jeffrey A. Jackson, Joseph Jankovic, Janet Ford Annals of Neurology	1983	146
Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects Amparo de la Peña, Matthew C. Riddle, Linda Morrow, Diabetes Care	2011	121
Prostatic Complications of Testosterone Replacement Therapy Jeffrey A. Jackson Archives of Internal Medicine	1989	98
Hypersecretion of Growth Hormone and Prolactin in McCune-Albright Syndrome* Leona Cuttler, Jeffrey A. Jackson, M. SAEED uz-ZAFAR, The Journal of Clinical Endocrinology & Metabolism	1989	97
Two Treatment Approaches for Human Regular U-500 Insulin in Patients With Type 2 Diabetes not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Titration-To-Target Clinical Trial Robert C. Hood, Richard F. Arakaki, Carol Wysham, Endocrine Practice Diabetes ManagementInsulin ManagementDiabetesPharmacologyType 2	2015	60
Symptomatic Osteoporosis in a Man with Hyperprolactinemic Hypogonadism Jeffrey A. Jackson Annals of Internal Medicine Symptomatic OsteoporosisReproductive HealthOsteoporosisOrthopaedic SurgeryInvasive Pituitary Macroadenoma	1986	40
Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog Jeffrey A. Jackson, Henry B. Hahn, Charles Oltorf, The Journal of Pediatrics MedicineNewborn MedicinePediatricsRefractory Neonatal Hypoglycemia	1987	40
Application of PK/PD Modeling and Simulation to Dosing Regimen Optimization of High-Dose Human Regular U-500 Insulin Amparo de la Peña, Xiaosu Ma, Shobha Reddy, Journal of Diabetes Science and Technology	2014	37

Page 1